IIVS at Upcoming Meetings
IIVS presented work from the following collaborations during the March 2013 Society of Toxicology meeting. Click on the abstract name to be directed to a page where you can read the abstract and access a full pdf of the poster. Please contact the IIVS author directly with any questions concerning this work, or to suggest new projects for publication.
Alternative Models Eye and Skin:
Abstract Number 957 Poster Board 338 - Application of a Modified KeratinoSens Assay to Predict Sensitization Hazard for Botanical Extracts
Abstract Number 972 Poster Board 353 - Validation of In Vitro and Clinical Safety Assessment of Behentrimonium Chloride-Containing Leave-on Body Lotions Using Post-marketing Adverse Event Data
Abstract Number 975 Poster Board 356 - The Inter-laboratory Reproducibility of the STE Test for Assessing Eye Irritation of Cosmetic Products
Abstract Number 976 Poster Board 357 - Choosing the Appropriate Solvent for Solid Materials Tested in the Bovine Corneal Opacity and Permeability (BCOP) In Vitro Assay
Abstract Number 979, Poster Board 360 - In Vitro Ocular Irritation Testing Strategy for Prototype Cleaning Products
Abstract Number 982 Poster Board 363 - Surfactant Responses in the Bovine Corneal Opacity and Permeability Assay: Points to Consider for In Vitro Eye Irritation Testing
Alternative High-Throughput Models I:
Abstract Number 1479 Poster Board 536 - Screening of Cosmetics Ingredients for Phototoxic Potential Using the In Vitro 3T3 Neutral Red Uptake Phototoxicity Test
IIVS will be exhibiting in Paris at the 2013 in-cosmetics meeting April 16-18 at stand S43 in the Testing and Regulation Zone. Stop by to learn about the in vitro testing services that we provide. You can visit our virtual booth here to arrange for a meeting sometime during the show.
Amanda Ulrey and Renee Forde will attend the 29th annual meeting of the Society of Quality Assurance in Indianapolis, Indiana. Three days of plenary and concurrent sessions will explore hot topics and the latest regulatory interpretations in the field. Sessions will focus on regulatory-based topics in manufacturing (GMPs), preclinical (GLPs) and clinical (GCPs) research arenas. Other areas of interest include animal health, bioanalysis, biotechnology, computer validation, medical devices, university issues and much more.